“Several oral (beta)-blockers are U.S. Food and Drug Administration-approved for migraine prophylaxis, but their gradual absorption and modification by first-pass metabolism delays effective plasma levels for hours to days, limiting their use in acute migraines,” Matthew Cossack, M.D., of the University of Missouri-Kansas City School of Medicine, and colleagues wrote. Read more.